Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Modified Mini-PCNL vs Standard PCNL for Complex Kidney Stones

Official title: Modified Mini Percutaneous Nephrolithotomy Versus Standard Percutaneous Nephrolithotomy for the Treatment of Complex Renal Calculi: A Multicenter Randomized Controlled Trial

Run by The First Affiliated Hospital of Guangzhou Medical University · NCT07697677 · Data updated 2026-11-12

This study tests whether a smaller 20 Fr access in modified mini-PCNL can match the stone-clearing success of the standard 24 Fr PCNL in adults with complex kidney stones.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment1380 (estimated)
SponsorThe First Affiliated Hospital of Guangzhou Medical University
Academic / other
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedJuly 15, 2026
Main results expectedJuly 14, 2027
Study endsSeptember 14, 2027
Registry record updatedJuly 13, 2026
Trial IDNCT07697677 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years and older with complex renal stones (stone surface area >1500 mm², multiple calyceal stones, staghorn or complex anatomy) and suitable ASA I-III status.

Probably not a fit

Patients with solitary kidneys, morbid obesity, prior renal transplantation, or other exclusion criteria may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter randomized trial compares modified mini-percutaneous nephrolithotomy using a 20 Fr access sheath to standard PCNL using a 24 Fr sheath in adults with complex renal stones. Participants are about 1,380 patients at 8 urology centers who will be randomly assigned to one of the two procedures. Stone-free status is checked with a low-dose CT within 72 hours after surgery, with follow-up assessment at 3 months. The goal is to determine non-inferiority of the modified mini-PCNL in achieving stone clearance while potentially reducing surgical trauma and recovery burden. Additional outcomes include perioperative safety and recovery metrics.

Why it matters

Potential benefit: If successful, patients may experience similar stone clearance with less surgical trauma and quicker recovery.

How similar studies have gone: Previous PCNL studies have shown that smaller tracts can reduce tissue trauma without compromising stone clearance in selected cases, supporting this trial's approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Adults aged ≥18 years.
2. Serum creatinine ≤133 μmol/L.
3. American Society of Anesthesiologists (ASA) physical status classification I-III.
4. S.T.O.N.E. score ≥8.
5. Complex renal stones confirmed by noncontrast computed tomography, including stone surface area \>1500 mm², multiple calyceal stones, partial or complete staghorn calculi, or complex anatomical conditions.
6. Patients who provide written informed consent and agree to undergo either modified mini-percutaneous nephrolithotomy or standard percutaneous nephrolithotomy.

Exclusion Criteria:

1. Solitary kidney.
2. Morbid obesity (body mass index ≥35 kg/m²).
3. Previous renal transplantation or urinary diversion.
4. Congenital abnormalities of the urinary tract.
5. Pregnancy.
6. Uncorrected coagulopathy.
7. Active urinary tract infection.

Where it's running

  • The First Affiliated Hospital of Guangzhou Medical University
    Guangzhou, Guangdong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.